Bullous pemphigoid induced by <scp>IgG</scp> targeting type <scp>XVII</scp> collagen <scp>non‐NC16A</scp> / <scp>NC15A</scp> extracellular domains is driven by Fc gamma receptor‐ and complement‐mediated effector mechanisms and is ameliorated by neonatal Fc receptor blockadeManuela Pigors, Enno Schmidt, Peter Verheesen et al.|The Journal of Pathology|2023Cited by 21
Increased Fibrosis in a Mouse Model of Anti-Laminin 332 Mucous Membrane Pemphigoid Remains Unaltered by Inhibition of Aldehyde DehydrogenaseSabrina Patzelt, Enno Schmidt, Heiko Steenbock et al.|Frontiers in Immunology|2022Cited by 12
Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseasesSaeedeh Ghorbanalipoor, Ralf J. Ludwig, Anika Kasprick et al.|Frontiers in Immunology|2022Cited by 9
Corrigendum: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseasesSaeedeh Ghorbanalipoor, Ralf J. Ludwig, Kathrin Kalies et al.|Frontiers in Immunology|2022Cited by 7
Anti-Laminin β4 IgG Drives Tissue Damage in Anti-p200 Pemphigoid and Shows Interactions with Laminin α3 and γ1/2 ChainsManuela Pigors, Enno Schmidt, Inke R. König et al.|Journal of Investigative Dermatology|2024Cited by 7